Timeline
Cambridge Cognition
Cambridge Cognition revenue rises 16% in first half
Cambridge Cognition raises minimum £2.5m to fund regulatory clearances and platform development
Cambridge Cognition launches brain health study with Oura
More in Healthcare Services
Tern investee Talking Medicines launches Intent to Prescribe tool
Talking Medicines, 23.8%-owned by IoT investor Tern, has added a prescribing-intent feature to its DrugVoice platform through new point-of-care data partnerships.